Keith Wycoff

Planet Biotechnology, Inc.

NIH Rank #8609
  • Early Career

NIH Funding · FY2024

Total Funding
$1.5M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#8,609
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.5M across 5 grants · National rank #8609.

Top grants by award amount

Keith Wycoff's NIH grant portfolio, ranked by award amount.

  • 5R41AI177227-02R41
    Factor H Fc fusions as novel therapeutics for Burkholderia pseudomallei infections
    $300K
    award amount
  • 1R41AI179571-01A1R41
    Developing a Potent Broad-Spectrum Prophylactic for Tickborne Disease
    $300K
    award amount
  • 1R41AI179576-01A1R41
    A broad spectrum anti-gonorrhea immunotherapeutic
    $300K
    award amount
  • 1R43AI186978-01R43
    Factor H-Fc Fusion as a Pre-Exposure Prophylactic for Rickettsia Infections
    $300K
    award amount
  • 1R43AI186979-01R43
    Bispecific antibody for topical administration to prevent gonorrhea
    $300K
    award amount

Affiliation

Institutions that have administered grants for Keith Wycoff.

Affiliated with Planet Biotechnology, Inc. (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Planet Biotechnology, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #8609

Related investigators

Other NIH-funded PIs frequently associated with Keith Wycoff.